Joint Pain Warning for Diabetes Meds
The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain that can be severe and disabling.
Trends in Treating Diabetes
Diabetes is a big problem in the US — and thus, it is a big focus of doctors, researchers and pharmaceutical companies alike. New medications and developments alter how diabetes is treated.
Diabetes Rx May Keep Arthritis at Bay
Call it a gut reaction. A popular diabetes medication works by helping gastrointestinal hormones that encourage insulin production. The same medication may also help ward off autoimmune diseases.
No Rise in Heart Attack Risk from Diabetes Rx
Saxagliptin helps diabetes patients control blood sugar levels. While it may not raise heart attack risk, the medication may have a negative effect on heart failure patients.
FDA Investigating Risk of Pancreatitis in Type 2 Diabetes Meds
The US Food and Drug Administration (FDA) is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia in patients with type 2 diabetes treated with a class of drugs called incretin mimetics.